AlphaCrest Capital Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-17,668
| Closed | -$128K | – | 1279 |
|
|
2022
Q2 | $128K | Buy |
+17,668
| New | +$128K | 0.01% | 1228 |
|
|
2022
Q1 | – | Sell |
-80,239
| Closed | -$1.28M | – | 1265 |
|
|
2021
Q4 | $1.28M | Buy |
+80,239
| New | +$1.28M | 0.05% | 674 |
|
|
2021
Q3 | – | Sell |
-76,800
| Closed | -$1.06M | – | 1256 |
|
|
2021
Q2 | $1.06M | Buy |
76,800
+33,260
| +76% | +$460K | 0.05% | 638 |
|
|
2021
Q1 | $636K | Sell |
43,540
-4,816
| -10% | -$70.3K | 0.04% | 689 |
|
|
2020
Q4 | $840K | Sell |
48,356
-10,218
| -17% | -$177K | 0.07% | 384 |
|
|
2020
Q3 | $1.07M | Buy |
58,574
+36,412
| +164% | +$668K | 0.12% | 236 |
|
|
2020
Q2 | $396K | Sell |
22,162
-9,659
| -30% | -$173K | 0.07% | 490 |
|
|
2020
Q1 | $516K | Buy |
31,821
+16,373
| +106% | +$266K | 0.06% | 556 |
|
|
2019
Q4 | $278K | Buy |
+15,448
| New | +$278K | 0.02% | 1099 |
|